Profound Medical Corp.
PROFNASDAQHealthcare● Active
$6.81
+$0.24(+3.65%)
Market Cap$206066500
P/E Ratio—
52W High$8.95
52W Low$3.76
Profound Medical Corp. (PROF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PROF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $42.32M | ($27.82M) | ($28.32M) | ($28.67M) | ($30.70M) |
| Depreciation & Amort. | $0.00M | $0.94M | $0.93M | $1.60M | $1.88M |
| Stock-Based Comp. | $0.00M | $2.58M | $3.42M | $4.24M | $7.21M |
| Change in Working Capital | ($2.39M) | $0.59M | $0.54M | ($5.63M) | ($0.88M) |
| Net Cash from Operations | ($53.34M) | ($23.45M) | ($22.61M) | ($25.80M) | ($22.36M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.25M) | $0.00M | $0.00M | $0.00M | ($0.59M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.34M) | $0.00M | $0.00M | $0.00M | ($0.59M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($1.82M) | ($2.56M) | ($0.91M) | $6.92M | ($0.39M) |
| Net Cash from Financing | $57.43M | $54.70M | $1.76M | $7.03M | $5.95M |
| Free Cash Flow | |||||
| Free Cash Flow | ($53.59M) | ($23.45M) | ($22.61M) | ($25.80M) | ($22.95M) |
| FCF Margin %(computed) | -327.16% | -230.67% | -314.06% | -386.17% | -333.96% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Profound Medical Corp. data
About Profound Medical Corp. (PROF) Cash Flow Statement
Profound Medical Corp. generated operating cash flow of ($0.05B) and free cash flow of ($0.05B) for 2025 — a FCF margin of -327.16%. Capital expenditure was ($0.00B).
Frequently asked questions
PROF · 4 questionsProfound Medical Corp. generated free cash flow of ($0.05B) for 2025, down 128.5% year-over-year.
PROF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10